EX-99.2 3 hcm-20240731xex99d2.htm EX-99.2

Exhibit 99.2

Dividends

No dividend has been declared or paid by the Company for the six months ended June 30, 2024 and 2023.

Reconciliation between US GAAP and International Financial Reporting Standards

These interim unaudited condensed consolidated financial statements are prepared in accordance with US GAAP, which differ in certain respects from International Financial Reporting Standards (IFRS). The effects of material differences prepared under US GAAP and IFRS are as follows:

(i)Reconciliation of condensed consolidated statements of operations

    

Six Months Ended June 30, 2024

IFRS adjustments

Tax effects of

intercompany

Amounts as

Lease

unrealized

 reported under 

 amortization 

profit

Amounts 

    

US GAAP

    

(note (a))

    

(note (b))

    

under IFRS

(in US$000)

Cost of goodsthird parties

(151,681)

31

(151,650)

Research and development expenses

(95,256)

49

(95,207)

Selling expenses

 

(27,351)

 

18

 

 

(27,333)

Administrative expenses

 

(30,460)

 

40

 

 

(30,420)

Total operating expenses

 

(333,202)

 

138

 

 

(333,064)

Other income, net

 

22,765

 

(91)

 

 

22,674

(Loss)/income before income taxes and equity in earnings of an equity investee

 

(4,756)

 

47

 

 

(4,709)

Equity in earnings of an equity investee, net of tax

 

33,807

 

6

 

(215)

 

33,598

Net income

 

26,165

 

53

 

(215)

 

26,003

Less: Net income attributable to noncontrolling interests

 

(364)

 

(7)

 

 

(371)

Net income attributable to the Company

 

25,801

 

46

 

(215)

 

25,632

    

Six Months Ended June 30, 2023

IFRS adjustment

Amounts as 

Lease

reported under 

 amortization

Amounts 

    

US GAAP

    

 (note (a))

    

under IFRS

(in US$000)

Cost of goodsthird parties

(182,380)

34

(182,346)

Research and development expenses

 

(144,633)

 

18

 

(144,615)

Selling expenses

 

(26,423)

 

23

 

(26,400)

Administrative expenses

 

(41,840)

 

80

 

(41,760)

Total operating expenses

 

(421,220)

 

155

 

(421,065)

Other income, net

 

25,434

 

(163)

 

25,271

(Loss)/income before income taxes and equity in earnings of an equity investee

 

137,088

 

(8)

 

137,080

Equity in earnings of an equity investee, net of tax

 

35,110

 

(2)

 

35,108

Net income

 

169,468

 

(10)

 

169,458

Less: Net income attributable to noncontrolling interests

 

(917)

 

(8)

 

(925)

Net income attributable to the Company

 

168,551

 

(18)

 

168,533


(ii)

Reconciliation of condensed consolidated balance sheets

June 30, 2024

IFRS adjustments

Tax effects of

Amounts as 

Lease 

intercompany

Capitalization

reported under 

amortization 

unrealized profit

Issuance costs

of rights

Amounts 

    

US GAAP

    

(note (a))

    

(note (b))

    

(note (c))

    

(note (d))

    

under IFRS

(in US$000)

Investment in an equity investee

80,519

(31)

90

80,578

Other non-current assets

37,274

(88)

14,907

52,093

Total assets

 

1,260,868

 

(119)

 

90

 

 

14,907

 

1,275,746

Additional paid-in capital

 

1,507,550

 

 

 

(697)

 

 

1,506,853

Accumulated losses

 

(845,068)

 

(131)

 

92

 

697

 

16,084

 

(828,326)

Accumulated other comprehensive loss

 

(9,534)

 

16

 

(2)

 

 

(1,201)

 

(10,721)

Total Companys shareholders equity

 

740,084

 

(115)

 

90

 

 

14,883

 

754,942

Non-controlling interests

 

11,934

 

(4)

 

 

 

24

 

11,954

Total shareholders equity

 

752,018

 

(119)

 

90

 

 

14,907

 

766,896

    

December 31, 2023

IFRS adjustments

Tax effects of

intercompany

Amounts as 

Lease 

unrealized

Issuance 

Capitalization 

LTIP 

reported under 

amortization 

profit

costs 

of rights 

classification 

Amounts 

    

US GAAP

    

(note (a))

    

(note (b))

    

(note (c))

    

(note (d))

    

(note (e))

    

under IFRS

(in US$000)

Investment in an equity investee

48,411

(37)

307

48,681

Other non-current assets

34,796

(137)

15,093

49,752

Total assets

 

1,279,773

 

(174)

 

307

 

 

15,093

 

 

1,294,999

Other payables, accruals and advance receipts

 

271,399

 

 

 

 

 

(10,502)

 

260,897

Total current liabilities

 

403,027

 

 

 

 

 

(10,502)

 

392,525

Total liabilities

 

536,386

 

 

 

 

 

(10,502)

 

525,884

Additional paid-in capital

 

1,522,447

 

 

 

(697)

 

 

10,502

 

1,532,252

Accumulated losses

 

(870,869)

 

(177)

 

307

 

697

 

16,084

 

 

(853,958)

Accumulated other comprehensive loss

 

(8,163)

 

14

 

 

 

(1,016)

 

 

(9,165)

Total Companys shareholders equity

 

730,541

 

(163)

 

307

 

 

15,068

 

10,502

 

756,255

Non-controlling interests

 

12,846

 

(11)

 

 

 

25

 

 

12,860

Total shareholders equity

 

743,387

 

(174)

 

307

 

 

15,093

 

10,502

 

769,115


Notes:

(a)

Lease amortization

Under US GAAP, for operating leases, the amortization of right-of-use assets and the interest expense element of lease liabilities are recorded together as lease expenses, which results in a straight-line recognition effect in the condensed consolidated statements of operations.

Under IFRS, all leases are accounted for like finance leases where right-of-use assets are generally depreciated on a straight-line basis while lease liabilities are measured under the effective interest method, which results in higher expenses at the beginning of the lease term and lower expenses near the end of the lease term.

(b)

Tax effects of intercompany unrealized profit

Under US GAAP, deferred taxes for unrealized profit resulting from intercompany sales of inventory is not recognized.  

Under IFRS, deferred taxes for unrealized profit resulting from an intercompany sale of inventory is recognized at the buyers tax rate.

(c)

Issuance costs

Under US GAAP and IFRS, there are differences in the criteria for capitalization of issuance costs incurred in the offering of equity securities.

(d)

Capitalization of development and commercial rights

Under US GAAP, the acquired development and commercial rights do not meet the capitalization criteria as further development is needed as of the acquisition date and there is no alternative future use. Such rights are considered as in-process research and development and were expensed to research and development expenses.

Under IFRS, the acquired development and commercial rights were capitalized to intangible assets. The recognition criterion is always assumed to be met as the price already reflects the probability that future economic benefits will flow to the Group.

(e)

LTIP classification

Under US GAAP, LTIP awards with performance conditions are classified as liability-settled awards prior to the determination date as they settle in a variable number of shares based on a determinable monetary amount, which is determined upon the actual achievement of performance targets. After the determination date, the LTIP awards are reclassified as equity-settled awards.

Under IFRS, LTIP awards are classified as equity-settled awards, both prior to and after the determination date, as they are ultimately settled in ordinary shares or the equivalent ADS of the Company instead of cash.